Poly(ethylene glycol)-Based Peptidomimetic “PEGtide” of Oligo-Arginine allows for efficient siRNA Transfection and gene inhibition

No Thumbnail Available
acsomega.9b00265.pdf(3.16 MB)
Published version
ao9b00265_si_001.pdf(1.23 MB)
Published version
Hibbitts, Alan
O'Connor, Aoife M.
McCarthy, Joanna
Forde, Éanna B.
Hessman, Gary
O'Driscoll, Caitríona M.
Cryan, Sally-Ann
Devocelle, Marc
Journal Title
Journal ISSN
Volume Title
American Chemical Society
Research Projects
Organizational Units
Journal Issue
While a wide range of experimental and commercial transfection reagents are currently available, persistent problems remain regarding their suitability for continued development. These include the transfection efficiency for difficult-to-transfect cell types and the risks of decreased cell viability that may arise from any transfection that does occur. Therefore, research is now turning toward alternative molecules that improve the toxicity profile of the gene delivery vector (GDV), while maintaining the transfection efficiency. Among them, cell-penetrating peptides, such as octa-arginine, have shown significant potential as GDVs. Their pharmacokinetic and pharmacodynamic properties can be enhanced through peptidomimetic conversion, whereby a peptide is modified into a synthetic analogue that mimics its structure and/or function, but whose backbone is not solely based on α-amino acids. Using this technology, novel peptidomimetics were developed by co- and postpolymerization functionalization of substituted ethylene oxides, producing poly(ethylene glycol) (PEG)-based peptidomimetics termed “PEGtides”. Specifically, a PEGtide of the poly(α-amino acid) oligo-arginine [poly(glycidylguanidine)] was assessed for its ability to complex and deliver a small interfering ribonucleic acid (siRNA) using a range of cell assays and high-content analysis. PEGtide–siRNA demonstrated significantly increased internalization and gene inhibition over 24 h in Calu-3 pulmonary epithelial cells compared to commercial controls and octa-arginine-treated samples, with no evidence of toxicity. Furthermore, PEGtide–siRNA nanocomplexes can provide significant levels of gene inhibition in “difficult-to-transfect” mouse embryonic hypothalamic (mHypo N41) cells. Overall, the usefulness of this novel PEGtide for gene delivery was clearly demonstrated, establishing it as a promising candidate for continued translational research.
Transfection efficiency , Gene inhibition , Cell viability , Gene delivery vector (GDV)
Hibbitts, A., O’Connor, A.M., McCarthy, J., Forde, E.B., Hessman, G., O’Driscoll, C.M., Cryan, S.A. and Devocelle, M., 2019. Poly (ethylene glycol)-Based Peptidomimetic “PEGtide” of Oligo-Arginine Allows for Efficient siRNA Transfection and Gene Inhibition. ACS Omega, 4(6), (10pp). DOI:10.1021/acsomega.9b00265